Hanan M Hassan

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Oxidative Stress

Ischemia Reperfusion Injury

Top Venues

Current Alzheimer research

Drug design, development and therapy

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kadi M Alharbi, Shahad A Alshehri, Wasayf A Almarwani, Khulud K Aljohani, Ajwan Z Albalawi, Areej S Alatawi, Shekha M Al-Atwi, Lama S Alhwyty, Hanan M Hassan, Mohammed M H Al-Gayyar
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis. Current Alzheimer research 21 (2) (2024)
Kadi M Alharbi, Shahad A Alshehri, Wasayf A Almarwani, Khulud K Aljohani, Ajwan Z Albalawi, Areej S Alatawi, Shekha M Al-Atwi, Lama S Alhwyty, Hanan M Hassan, Mohammed M H Al-Gayyar
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis. Current Alzheimer research (2024)
Hanan M Hassan, Yasmen F Mahran, Amal M H Ghanim
Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways. The Journal of pharmacy and pharmacology 73 (9) (2022)
Hanan M Hassan, Lamya H Al-Wahaibi, Mohammed A Elmorsy, Yasmen F Mahran
Suppression of Cisplatin-Induced Hepatic Injury in Rats Through Alarmin High-Mobility Group Box-1 Pathway by Ganoderma lucidum: Theoretical and Experimental Study. Drug design, development and therapy 14 (2020)